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Glycans, as potential prognostic biomarkers, deserve attention in clinical 
glycomics for diseases diagnosis. The variety of glycan chains, attached to proteins 
and lipids, makes it possible to form unique glycoconjugates with a wide range of 
cellular functions. Under leukocyte-endothelial interaction, not only the availability 
of glycoconjugates with sialic acids at the terminal position of glycans are informa-
tive, but also the type of glycosidic bond by which sialic acids links to subterminal 
carbohydrates in structure of glycans. The process of sialylation of leukocyte 
glycoconjugates undergoes considerable changes in type 1 diabetes mellitus. At 
early stage of disease without diabetic complications, the pathology is accompanied 
by the increase of α2,6-linked sialic acids. The quantity of sialic acid-containing 
glycoconjugates on leukocytes surface increases in condition of disease duration 
up to five years. However, the quantity of sialic acids linked by α2,6-glycosidic 
bonds decreases in patients with the disease duration over ten years. Therefore, 
sialoglycans as marker molecules determine the leukocyte function in patients with 
type 1 diabetes mellitus, depending on the disease duration. Changes in the glycans 
structure of membrane glycoconjugates of leukocytes allow understanding the 
mechanism of diabetic complications development.
Keywords: sialic acid, glycans, glycoconjugates, sialyltransferases, sialidases, 
leukocytes, type 1 diabetes mellitus
1. Introduction
Glycans, as potential biomarkers of health and illness, deserve attention in 
clinical glycomics for early-stage disease diagnosis [1, 2]. It is not surprisingly that 
abnormal (aberrant) glycosylation of proteins and lipids have been observed in 
many diseases, including cancer, cardiovascular disease, immune deficiencies and 
diabetes [3].
Diabetes mellitus (DM) is one of the most common endocrine diseases that 
have been identified as one of the priority issues for national health systems around 
the world. Type 1 DM is characterized by a progressive autoimmune destruction 
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of pancreatic β-cells, leading to insulin deficiency and chronic hyperglycemia [4]. 
The social significance of this problem is that DM associated with development of 
numerous concomitant diseases, early disability, and metabolic complications [5]. 
Insufficient control of glucose level in blood may increased the risk of microvascu-
lar (nephropathy, retinopathy, neuropathy) and macrovascular (peripheral artery 
disease, coronary artery diseases, congestive heart failure, myocardial infarction, 
stroke) complications. In addition, individuals with DM have increased risk of 
physical and cognitive disability, depression and cancer [6]. The various complica-
tions related to diabetes are determined by changes of blood components. Blood 
cells (leukocytes, erythrocytes and thrombocytes) are of particular interest because 
they are directly exposed to high glucose concentrations [7]. Blood cells aggregate 
strongly to the vessel wall and adhere to each other, which leads to the development 
of pathological changes in capillary blood flow and microcirculation disorders in 
diabetes [4–6].
Leukocytes are the major cells of the inflammatory and immune response that 
defends against different type of infection, consequently these cells are important 
object for investigation [5]. The сlinical and experimental studies of human blood 
in case of DM and animals with streptozotocin-induced diabetes demonstrate 
significant violations of the morphofunctional state of leukocytes. The dysfunction 
of chemotaxis capacity, adhesion and migration, reduction of phagocytic activity 
and bactericidal ability of leukocytes correlate with the level of hyperglycemia in 
blood [8, 9].
The impairment in the functions of immunocompetent cells leads to a decrease 
in immune defense and the development of chronic infectious/inflammatory 
processes in organism of people with type 1 diabetes [10]. Chronic inflammation 
is the main cause of progression of diabetic complications which leads to dysfunc-
tion of the extremities, retina, kidneys, nerves, heart and blood vessels. According 
to statistics, most of patients die from angiopathic complications of diabetes. 
Screening of complications provides with possibility to reduce the risk for their 
development and progression [11]. Therefore, expansion of diagnostic methods 
for characterization of changes in the morphofunctional state of leukocytes and 
the search for preventive remedies that would ameliorate the clinical condition of 
patients is a relevant problem today.
2.  Importance of membrane glycoconjugates in providing the functional 
activity of leukocytes
Experimental studies have shown that cells of the immune system are exposed 
to the direct and indirect effects of high blood glucose concentrations in patients 
with diabetes [4, 5]. Glucose metabolism pathways are activated under condi-
tions of hyperglycemia include the autooxidation of glucose, caused glycation of 
long-lived proteins; the hexosamine pathway, which leads to the glycosylation of 
hydroxyl-containing amino acid residues; sorbitol metabolism, accompanied by the 
formation of free radical; and oxidative phosphorylation leading to mitochondria 
electron transport chain intensification and the generation of superoxide-anion 
radicals [12, 13]. Glucose autooxidation and glycation of proteins and lipids leads 
to an accumulation of advanced oxidation protein products and advanced glycation 
end products (AGEs), which are difficult to eliminate from the blood and remain 
in circulation [14]. They are also the source of reactive oxygen species (ROS) since 
they imitate metal containing oxidation systems. Excessive formation of ROS and 
reactive nitrogen species (RNS) leads to the development of oxidative-nitrative 
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stress [15]. These changes create a favorable background for the formation of 
micro- and macrovascular diabetic complications [15, 16].
In condition of hyperglycemia, leukocytes are preactivated by ROS and RNS, 
angiotensin II, and AGEs. The interaction of AGEs with their receptors, RAGE, causes 
intracellular signal transduction, which leads to changes in gene expression, overpro-
duction of free radicals, the release of pro-inflammatory molecules (tumor necrosis 
factor α (TNFα), interleukin 1β (IL-1β), IL-2, IL-6 etc.), and changes in the activity of 
intracellular enzymes [17].
Glycosyltransferases and glycosidases, which involved in the synthesis of glycans 
of glycoconjugates, pay much interest among cellular enzymes [18]. In general, 
mammalian glycans are the product of several types of glycohydrolases and dozens 
of glycosyltransferases, which act sequentially in the process of oligosaccharide 
chains synthesis. Each of the glycosyltransferases uses one type of sugar substrate 
and forms a specific bond between one monosaccharide and a glycan precursor. 
Thus, the set of glycosyltransferases in the cell determines what type of glycans, 
among the large number of possible structures, will be formed [19].
The variety of monosaccharides is very large, but most often the carbohy-
drate components of glycoconjugates of eukaryotic cells include glucose (Glc), 
N-acetylglucose (GlcNAc), galactose (Gal), N-acetylgalactose (GalNAc), man-
nose (Man), N-acetylneuraminic acid (Neu5Ac), also known as sialic acid (Sia). 
Different monosaccharides, combined in a specific sequence by glycosyltrans-
ferases, form a glycan, which at one end attaches to a protein or lipid molecule. 
The formed glycoconjugates are the main macromolecular constituents of 
biomembranes [19, 20].
The diversity of glycans attached to proteins and lipids makes it possible to form 
unique glycoconjugates with a wide range of cellular functions. Glycoconjugates 
play an important role in various biological processes, in particular, glucose 
homeostasis, protein quality control, cellular differentiation, adhesion, intercellular 
signaling and inflammation. It is known that carbohydrate residues increase the 
solubility of glycoproteins, protect against proteolysis, influence on their fold-
ing, intracellular transport and secretion. Glycoconjugates are components of the 
glycocalyx, providing specific interactions with ligands, intercellular contacts and 
communication. Glycans of glycoconjugate are involved in the formation of the 
immune response, blood clotting and provide the individuality of organisms and 
their plasticity [20].
The immune system is highly controlled and fine-tuned by glycosylation, 
through the addition of a variety of glycans to virtually all adhesion molecules and 
receptors of leukocytes. Glycoconjugates are implicated in fundamental cellular 
and molecular processes. Glycans perform function of molecular recognition that 
regulates both stimulatory and inhibitory immune pathways [21]. The presence of 
modified carbohydrate determinants in the glycan structure modifies the biologi-
cal activity of the entire glycoconjugate. The interaction of specific ligand with 
its modified receptor leads to violations at the level of transmembrane and intra-
cellular signaling [22]. In according to the importance of glycans in the immune 
system, scientific researches emphasize the essential contributions of glycosylation 
in the regulation of innate and adaptive immune responses [21]. Therefore, today 
the scientists (biochemists, molecular biologists, immunologists, pathologists 
and pharmacologists) are making the great efforts to explore the interrelations of 
carbohydrate determinants with their glycobiology. Establishing changes in the 
glycans structure of membrane glycoconjugates of immunocompetent cells makes 
it possible to understand the mechanism of pathological changes in condition of 
diabetes and diabetic complications.
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Thus, changes in intracellular metabolism, intensification of glycation processes 
and the development of oxidative-nitrative stress in blood cells under conditions of 
prolonged hyperglycemia are the main factors that induce pathological changes in 
the structure of their components and affect their functional state [12, 20].
3.  Sialoglycoconjugates of leukocytes as the main regulators of 
molecular and cellular interactions
Glycoconjugates of leukocytes contain sialic acid as the terminal sugar and play 
important roles in many physiological processes. Sialic acid normally exists in the 
periphery of non-reducing end of the oligosaccharide chains of many glycoproteins 
and glycolipids. They are involved in carbohydrate-protein interactions during cell 
recognition, in cell–cell interactions involving functional receptors, in the bind-
ing of pathogens such as viruses, bacteria or parasites [19, 23]. Sialic acids are also 
implicated in the processes of activation, differentiation, survival and apoptosis of 
leukocytes. Sialoglycoconjugates affects cellular adhesiveness, antigenicity, action 
of some hormones, catalytic properties of enzymes, modulating the affinity of cell 
surface receptors and transmembrane signaling [19, 20]. It is obvious that sialic 
acids are important molecular determinants of many immune processes. To imple-
ment these functions, organisms have a range of proteins (sialospecific lectins) that 
recognize surface-exposed sialic acids in glycoconjugates [19].
The variety of functions indicates the importance of sialic acid in cell biology. 
The biology of sialic acids should be considered from the point of view of their 
dual function. On the one hand, sialic acid acts as biological mask agent by mask-
ing recognition sites such as receptor molecules of cell membranes. On the other 
hand, sialic acid plays a role as recognizable cell patterns. Sialic acids as ligands 
are recognized by lectins, antibodies, hormones or as receptors recognize extra-
cellular markers in the molecular processes of cell interactions [23–25]. Activation 
of cells can lead to the opening of ligand-binding sites with a subsequent increase in 
binding affinity, lowering the cellular activation threshold, or removal of inhibitory 
signals [26, 27].
Sialic acids can participate directly or indirectly in multiple cellular events and 
overall immune response [28]. Sialic acids contribute to cells being “self” and, thus, 
weakens immunoreactivity. That is why they are not recognized by immune system 
cells or macrophage lectins. The loss of these masking monosaccharides makes 
the cell “foreign”, activating the body’s immunoreactive response. Therefore, sialic 
acids can be considered components of innate immune protection [29]. These acids 
have recently been recognized as being involved in most important phenomena of 
molecular and cellular interactions in immune regulation [30, 31]. In this respect, 
sialic acids have been associated with inflammatory diseases, malignancies, cardio-
vascular disease and diabetes [32].
Sialic acids are group of monosaccharides with high structural diversity, which 
are chemically derived from nine carbon acidic sugars – neuraminic acids. The most 
abundant member of the family carries an acetyl moiety linked to the amino group 
of fifth carbon (C5) giving the Neu5Ac. A feature of its structure is the presence of 
a carboxyl group near C1, which determines the negative charge of the molecule at 
physiological pH and characterizes it as a strong organic acid (pK 2.2). More than 
fifty derivatives of neuraminic acids have been found in nature. The most common 
sialic acid derivatives found in mammals are Neu5Ac and N-glycolylneuraminic acid 
(Neu5Gc), whereas in humans Neu5Ac is the dominant sialic acid [19, 23, 33].
Due to their negative charge at physiological pH and hydrophilic property sialic 
acids stabilize conformation of molecules, can impact protein oligomerization, the 
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interactions of proteins with other proteins and the extracellular matrix. Sialic acids 
as an essential compound of all cell membranes play an important role in maintain-
ing the structure, permeability and integrity of the cell membrane [28, 34]. Not 
surprisingly, sialic acid exponation is dynamic, changes during development and 
is altered in numerous diseases [35]. Changes in sialylation are associated with 
oxidative stress induced by several disorders including diabetes. It has been proven 
that level of sialic acid increased in plasma in condition of inflammatory processes 
and DM [36]. The relation between sialic acid and diabetes duration most likely 
follows from the association sialic acid with microvascular complications, which 
are well established to be related to glycemic control [37]. Therefore, sialic acid 
concentrations in the blood may be a useful marker of the development of diabetic 
complications, but there have been no many studies examining the link between 
sialoglycoconjugates and complications in type 1 DM.
The structural diversity of sialoglycoconjugates is due not only to the diversity 
of derivatives of sialic acids in their composition, but also depends on the type of 
glycosidic linkages (2,3, 2,6, 2,8, and 2,9) with subterminal sugars. The sialylation 
of oligosaccharide chains of glycoconjugates is carried out with the participa-
tion of the family of enzymes sialyltransferases (STs). About 20 STs have been 
characterized [19]. STs are divided in four main subfamilies, namely the ST3Gal, 
ST6Gal, ST6GalNAc and ST8Sia, depending on the glycosidic linkage formed and 
the monosaccharide acceptor recognized [35, 38]. ST3Gal, ST6Gal, ST6GalNAc and 
ST8Sia link Neu5Ac via its C2 to the C3, C6 positions of other carbohydrates or the 
C8, C9 positions of another sialic acids, generating α2,3-, α2,6-, α2,8, or α2,9-linked 
sialic acids, respectively [19, 39]. Sialyltransferase-mediated addition of sialic acid 
on glycans usually stops their further growth and modifies charge, steric hindrance, 
conformation and flexibility, underlying the importance of STs in shaping the 
structures and functions of sialoglycans [35, 40].
In the structure of leukocytes’ glycans sialic acids are frequently the terminal 
residues of glycans and are mostly attached either by a 2,3- or 2,6-glycosidic bond to 
Gal or GalNAc of oligosaccharide chains [19]. The ST6Gal and ST6GalNAc, which 
are present in leukocytes, catalyze the transfer of Neu5Ac from CMP-Sia (cytidine-
5′-monophospho-N-acetylneuraminic acid) to the C6 hydroxyl group of a terminal 
Gal or GalNAc residues, respectively, with the formation of α2,6-linkaged sialic 
acids in the oligosaccharide chains of glycans [19, 20, 38]. The ST3Gal comprises 
family with six members (ST3Gal I–VI). The expression of ST6Gal-I is tissue spe-
cific and regulated by multiple transcriptional promoters [41, 42]. An inducible and 
liver-specific promoter drive high ST6Gal-I expression during inflammation with 
increase in secreted ST6Gal-I in blood [43]. Activated platelets release the CMP-Sia 
that serves as the donor for circulating ST6Gal-I, allowing for the remodeling of 
the glycans of hematopoietic stem cells and multipotent progenitors (HSC/MPPs) 
[44]. Thus, inducible promoter is important for regulation of hematopoiesis [45]. 
The ST3Gal-V add a sialic acid to terminal Gal residues with the formation of α2,3-
glycosidic linkage, while ST3Gal-IV sialylates Galβ1,3GalNAc terminated structures 
in glycoconjugates and Galβ1,4(3)GlcNAc structures found on N- and O-glycans 
[46]. The ST3Gal-IV and ST3Gal-VI involved in the synthesis of the sialyl LewisX 
(sLeX) determinant on leukocyte E-, L- and P-selectin ligands [19, 46]. Leukocytes 
express a number of different selectin ligands, including E-selectin ligand-1, 
P-selectin glycoprotein ligand-1, CD43, CD44, β2-integrins, ets. [35, 47].
Glycosylation of cell-surface structures of leukocytes is important in the 
accomplishment of the immune function by these cells in organism. The mem-
brane structures of leukocytes are decisive in the processes of extravasation, the 
migration of leukocytes from blood vessels into the extracellular space. In order 
to penetrate the vascular wall, leukocytes initially interact with the endothelium, 
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roll over its surface, undergo dense adhesion, dissolve, and finally move through 
or between endothelial cells of the blood vessel [48–50]. Leukocyte chemotaxis 
depends on the surface sLeX and E-selectin of vascular endothelial cells. E-, L- and 
P-selectins are exposed by endothelial cells, leukocytes and platelets, respectively. 
Selectins are carbohydrate-binding proteins that recognize the sLeX structure 
(Neu5Acα2,3Galβ1,4(Fucα1,3)GlcNAcβ-R), capping N- and O-glycans as specific 
ligands [51–53]. These sialic acid-containing moieties are required for leukocyte 
binding to selectins on endothelial cells and their rolling [54, 55]. Combinatorial 
knockout of ST3Gal-IV and ST3Gal-VI that are the involved in sLeX synthesis leds to 
a decrease in neutrophil binding to E- and P-selectins, selectin-dependent rolling, 
and lymphocyte homing [46]. The selectin profile of cells can change under the 
influence of cytokines in case of development of inflammatory process, infection or 
under the influence of ROS. In tissue inflammation, cytokines stimulated endo-
thelial cell production of E-selectin, which could recognize sLeX on the leukocyte 
surface and bind it, promoting leukocyte adhesion to the vascular endothelium and, 
subsequently, to the inflammatory tissue or locations of injury [32, 56]. Therefore, 
the recognition of all types of selectins is mediated with sialic acid residues [19].
In the catabolism of sialoglycans of glycoconjugate involved extracellular and 
intracellular sialidases, a glycoside hydrolase, that specifically hydrolyze release 
α-linked sialic acid residues through hydrolysis of the glycosidic bond between the 
acidic sugar(s) and the internal acceptor. Four different sialidases (also termed 
as neuraminidases – NEUs) in mammalian cells, NEU1, NEU2, NEU3 and NEU4, 
have been described [57]. These NEUs exhibit differences in cellular localization, 
substrate specificities, physiological functions and expression patterns in different 
tissues and physio/pathological conditions [35, 57, 58]. The NEU1 is found in the 
lysosome and on the cell surface and is the most highly expressed of this sialidase 
family [35]. The level of NEU2 is extremely low and the content of NEU3 and 
NEU4 are about 10% of NEU1 in tissue separately [57]. The lysosomal sialidase 
NEU1 initiates the degradation of sialoglycoconjugates [59]. The NEU1 is capable 
of hydrolyzing a wide range of glycoproteins, oligosaccharides and ganglioside near 
neutral pH. It exclusively acts on glycoproteins and preferentially cleaves α2,3-
linkages over α2,6- or α2,8-linkages [19, 35]. In addition, NEU1 may have extralyso-
somal localization and focus on the periphery of activated lymphocytes. The NEU1 
controls several aspects of the immune response by the desialylation of molecules, 
such as Toll-like receptor 4 and adhesion molecules involved in the recruitment 
of leukocytes to inflammatory sites [35, 57]. Desialylation of sialyl α2,3-linked 
Gal residues of Toll-like receptor 4 is essential for receptor activation and cellular 
signaling [60]. The cytosolic sialidase (NEU2) can hydrolyze sialic acids from 
glycoproteins and gangliosides [61]. The plasma membrane-associated sialidase 
(NEU3) is a key enzyme for ganglioside hydrolysis [57]. The NEU4 is localizing in 
the lysosomal lumen or bound to the outer mitochondrial membranes via pro-
tein–protein interactions or the ER membrane-associated. Its exhibits the highest 
activity with gangliosides as well as sLeX and sLea antigens [35, 57, 58]. Sialic acid is 
actively exfoliated from the cell surface by extracellular sialidases during leukocyte 
activation. This process plays an important regulatory role in cell activation and 
differentiation [62].
Metabolism of sialic acids includes the cooperation of enzymes that catalyze the 
biosynthesis, activation, transfer of sialic acids to glycoconjugates, as well as the 
removal and degradation of sialic acids [63]. The aberrant expression of STs and 
NEUs accelerates and sustains sialylation status on glycoconjugates [64]. Therefore, 
knowledge in this field of glycobiology allows to predict biological events in case 
of increase or decrease in the amount of sialoglycoconjugates on the cell surface 
or under conditions of modification or structural changes of these acids in certain 
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types of cells. Thus, STs, NUEs and sialic acids itself represent important therapeu-
tic targets for medicinal chemistry and biopharmaceutical industry [65, 66].
4.  Lectins as diagnostic molecular probes for determining the 
glycosylation profile and structural changes of glycans
Glycocode information is read in living organisms with the help of specific 
compounds – lectins. Lectins are sugar-binding proteins that can specifically rec-
ognize glycans of glycoconjugates without disrupting the structure of the recogniz-
able carbohydrate-containing ligands.
Since surface glycoconjugates have a unique structure for each cell type, they can 
be identified, quantified and characterised structural changes in glycans using spe-
cific lectins. Nowadays, lectins, their properties, the importance of these proteins 
in the life of organisms and their applying in experimental biology and medicine 
are the subject of research in the world’s science laboratories. Lectins excluded 
from living objects are valuable biochemical reagents that are used in experimental 
cytochemistry, in the diagnosis of some diseases, and in biotechnology for isolating 
certain carbohydrate-containing molecules [20, 67].
Interactions of sialic acids with lectins play a leading role in many physiological 
and pathological processes. Therefore, sialospecific lectins are used to recognize 
sialic acids with specific linkages to subterminal sugars. Wheat germ lectin (WGA) 
specifically binds to β,DGlcNAc and Neu5Ac. The Maackia amurensis lectin (MAA) 
and Sambucus nigra lectin (SNA) are commonly used to recognize the α2,3-linked 
(Neu5Acα2,3Gal) and α2,6-linked (Neu5Acα2,6Gal/GalNAc) sialic acid residues, 
respectively [20, 68, 69]. Sialospecific lectins apply in lectin microarray [70], 
histochemistry [71], in lectin blot [72, 73], fluorescent image and flow cytometry 
[74] (Figure 1). At the same time, the combination of lectins with monoclonal 
antibodies can be used to obtain complete information on the antigenic repertoire 
of cells both in normal and in case of pathologies [73].
Blood leukocytes are similar in structural organization, and, at the same time, 
they differ significantly in biochemical structure. It is very important to understand 
the morphofunctional state of the cell is to be able to detect these differences. 
Numerous methods are used for this purpose [70]. Aggregatometry is one of 
the assays used to evaluate the functional properties of platelets, leukocytes and 
erythrocytes in the dynamics, monitor antiplatelet therapy, study the mechanisms 
of aggregation. The aggregation capacity of cells is assessed by such parameters as 
the degree, rate and time of aggregation [20].
The substances of protein (lectins, proteolytic enzymes, chemoactive pep-
tides); lipid (metabolites of arachidonic acid, liposomes); carbohydrate (heparin, 
dextransulfates) or other nature (phorbol esters, amphotericin B, ADP, organic 
dyes – alcyanine blue, ruthenium red) can be inducers of aggregation. Lectins used 
in aggregatometry are divided into lectins-mitogens (СonA, PHA) and polyvalent 
lectins (WGA, SNA). Polyvalent lectins have two or more binding centers of carbo-
hydrate determinants (carbohydrate-recognition domains) on the cell surface. The 
aggregation of cells by such lectins is due to the formation of intercellular molecular 
bridges. The ability of each subunit of lectin to bind sugars individually leads to 
the formation of a cross-linked structure of the aggregate. The efficiency of lectin-
induced aggregation is determined by the processes of clustering of lectin receptors 
on the cell surface [20, 75].
The aggregation capacity of leukocytes is studied to model their pre-migratory 
state before leaving the bloodstream, i.e. before diapedesis, or to analyze phagocytic 
activity. It is consider that phagocytosis involving lectin-carbohydrate interactions 
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is one of the oldest evolutionary forms of this process [76]. Phagocytosis during 
evolution was significantly displaced by antigen–antibody interactions, but did not 
lose importance in the formation of a nonspecific immune response [77].
5.  Сhanges of carbohydrate determinants of glycoconjugate mediate the 
functional state of leukocyte in type 1 DM
Leukocytes are markers of the immune homeostasis and receive signals from 
the microenvironment through the glycans of receptors. Lectins of certain car-
bohydrate specificity are ligands that selectively activate chemokine receptors. 
The response of cells to lectins in vitro makes it possible to analyze the chemical 
structure of the carbohydrate determinants of glycoconjugates on the membrane of 
leukocytes [66, 78].
Lectins WGA, SNA and MAA, which specific to sialic acids, are used to deter-
mination sialylated glycoconjugates and differentiation various types of sialic acid 
links with subterminal carbohydrates of glycans (SNA recognizes α2,6-links, while 
МАА identifies α2,3-links, Figure 2) [75, 79].
Alteration of the amount of sialic acids on the surface of leukocytes is an 
additional level of regulation of cells affinity to signaling molecules (cytokines, 
hormones), pathogenic microorganisms and determines the nature of cell–cell 
interactions [20].
Figure 1. 
Examples of uses of lectins in glycobiology. Many plant and animal lectins are multivalent. In particular, 
the lectin is shown with four carbohydrate binding domains. (A) Lectins bind of surface glycoconjugates of 
leukocytes, causes cell aggregation. (B) Histochemical analysis of surface glycans. (C) Enzyme linked lectin 
assay: biotinylated lectins bind to glycoconjugates on the surface of cells immobilized to the bottom of the well of 
a flat-bottomed plate; bound lectins are detected by antibodies to biotin with horseradish peroxidase.
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The most significant changes of increasing lectin-induced aggregation of 
leukocytes in type 1 diabetes have been observed using lectin WGA. An increase in 
the degree and rate of WGA-induced aggregation of neutrophils in diabetes is a sign 
of increased of N-acetyl-β,D-glucosamine-containing and sialic acid-containing 
glycoconjugates on surface of leukocytes [80]. This indicates that synthesis of 
hybrid types of N-glycans is occured by activated N-acetylglucosaminyltransferase-
III (GnT-III) and incomplete glycosylation of proteins and lipids [20]. As a result, 
glycoconjugates with terminal β,D-GlcNAc residues are exhibited on the leukocyte 
surface and determined high rates of WGA-induced aggregation [81].
The structural characterization of neutrophils glycoconjugates showed that 
cell surface N-glycans are highly sialylated, and many of their “antenna” play 
an important role in selectin-mediated neutrophil circulation [82]. Glycome of 
neutrophils is consisted mainly of complex bi- tri- and tetra-antennary N-glycans 
(Figure 2). Their antennae are predominantly terminated with Neu5Ac and LeX 
(Galβ1,4(Fucα1,3)GlcNAc) epitopes [83]. The ST3Gal-IV knockout results in 
significant reduction in the synthesis of sLeX structures in neutrophils. These 
cells show significant impairment in rolling and adhesion to the endothelial cells 
[84]. All these structural changes in the carbohydrate chains of glycoconjugates of 
leukocytes induce disturbances of molecular signals perception from the microen-
vironment, affecting interaction of leukocytes with other circulating blood cells 
and vascular endothelium in condition of diabetes [7, 20, 85].
Sialic acids can mask, i.e. change the structure of carbohydrate components 
of various specific receptors on the cell surface [19]. There is the receptor to 
N-formyl-methionyl-leucil-phenylalanine, C5a component of the complement 
system, IL-8, the receptor of granulocyte-monocyte colony-stimulating factor and 
the cell receptor 3 (Mac-1) among WGA-binding glycoproteins. The interaction of 
neutrophils with the intercellular adhesion molecule 1 (ICAM-1, CD54), which is 
involved in the adhesion of leukocytes to the vascular endothelium occurs via the 
Maс-1 receptor. On the other hand, WGA-specific receptors are involved in the 
Figure 2. 
The structure of leukocyte sialic acid-containing membrane glycans in physiological state of cells and in type 1 
diabetes. Sialic acids, depending on the type of glycosidic bond in the structure of the glycan, are recognized by 
WGA, SNA and MAA lectins.
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stimulation of respiratory burst in neutrophils by activating NADPH oxidase and 
followed formation of ROS [86–88].
The content of GlcNAc and Neu5Ac residues in glycans of glycoconjugates of 
the plasma membrane of neutrophils increases in type 1 diabetes [72]. It may be 
one of the main causes of nonspecific damage of tissues and cells, which are close to 
stimulated neutrophils. Under such conditions, neutrophils produce ROS and cause 
erythrocytes, platelets, fibroblasts and endotheliocytes death, inactivate enzymes, 
lead to changes in the structure of proteins and lipid peroxidation [6, 20].
Interaction of glycoconjugates of polymorphonuclear leukocytes with lectin 
SNA changes significantly under DM [80]. The level, velocity and time required 
for the maximum neutrophilic granulocyte aggregation in patients with type 1 DM 
duration of up to 5 years have been different from these indicators in patients with 
diabetes lasting more than 10 years. In particular, in the early stages of the disease, 
the degree of neutrophils aggregation, as well as the rate of SNA-induced aggrega-
tion have been four times higher than in patients with the disease over ten years 
[20, 80]. It is assumed that with the disease progresses, changes in leukocytes are 
associated with neutrophil subactivation processes that lead to the release of gra-
nule contents into the extracellular space, especially intravascularly. Degranulation 
leads to the lowering of cells aggregation [88, 89]. It is known that elevated glucose 
levels inside the cell have an inhibitory effect on a number of enzymes that are 
involved in the biosynthesis of the oligosaccharide chain of glycans. One of such 
enzymes is STs, which catalyze the attachment of sialic acid to the terminal sugar 
in glycan structure [19, 39]. Hyperglycemia is probably one of the factors that 
 mediates the glycan profile violation of leukocytes in diabetes.
Decreased aggregation of neutrophils in patients with DM under the addition 
of MAA lectin indicates the presence sialic acids in the structure of glycoconju-
gates of neutrophil membranes in a small amount. These α2,3-linked sialic acids 
affect both the dynamic and kinetic parameters of the neutrophil aggregation 
process [72, 90]. The decrease in sialic acid content in the cellular glycocalyx is 
most often due to the enhanced desialylation of the membrane glycoconjugate. 
It is worth noting that sialic acids which are linked to subterminal sugars of the 
glycoconjugates oligosaccharide chains by the α2,3-glycoside bond are much more 
likely to undergo hydrolytic cleavage by sialidases than α2,6-linked residues of 
these sugars [90]. Cleavage of sialylated oligosaccharide fragments from glyco-
conjugates or exfoliation of the whole molecules of sialoglycoconjugates can be 
another reason of loss of sialic acids from the cell surface. However, there is often 
a combination of all these factors [20, 81]. Decreased α2,3-linked sialic acid on the 
surface of leukocytes leads to impaired perception of signals from the extracellular 
space, interaction with other cells, as well as numerous bacteria, protozoa and 
viruses. Desialylation of surface glycoconjugates of polymorphonuclear leukocytes 
leads to increasing of their adhesive properties, which promotes the migration of 
neutrophils through the vascular endothelium [91].
The interaction of glycoconjugates of mononuclear leukocytes with lectin MAA, 
which reacts with Neu5Acα2,3 Gal/GalNAc terminal endings glycan, have been 
markedly inhibited under diabetes [90, 92]. It has been found that the decrease in 
sialic acid content usually occurs due to increased activity of endogenous sialidases 
in activated T cells and monocytes [46]. This leads to increased production of 
cytokines by lymphocytes and interaction of monocytes with hyaluronic acid – a 
component of extracellular matrix [93, 94]. The NEU1 and NEU3 are expressed in 
monocytes in the process of their differentiation into macrophages. Desialylation 
of glycans on the surface of monocytes by exogenous NEU resulted in activation 
of ERK1/2 and p38 MARK signaling pathways and increased production of IL-6, 
IL-1β, MIP-1α and MIP-1β [94, 95]. Рro-inflammatory cytokines cause endothelial 
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dysfunction by increasing capillary permeability, inducing prothrombotic proper-
ties, promoting leukocyte recruitment by synthesis of adhesion molecules and 
chemoattractants, and play a role in macroangiopathy by promoting dyslipidemia. 
Thus, it is unlikely that the increased circulation of sialic acid is the result of 
 desialylation of glycoconjugates. However, there is evidence that sialic acid is 
reduced in endothelium and erythrocytes in diabetes, which may be important in 
the pathophysiology of vascular disease [37].
Due to fact that terminal α2,3-linked sialic acids are included, in particular, 
in the structure of the CD45 receptor, which mediated an increasing of T cell 
proliferation [96], the decrease content of sialic acids in type 1 diabetes indicates 
a violation of this function in immunocompetent blood cells. Studies showed that 
the sialylation of T cell CD45 by ST6Gal-I blocks galectin-1 clustering of CD45 
and resulting cell death [97]. The α2,6-sialylation of FasR blocks binding of Fas-
associated adaptor molecule to the FasR death domain, thus inhibiting the forma-
tion of the death-inducing signaling complex [98].
Lectins SNA and MAA interact with CD45+ leukocytes [96]. CD45 is a trans-
membrane glycoprotein found on T, B, NK cells, granulocytes, and monocytes. It 
has a cytoplasmic tail with cytosolic phosphotyrosine phosphatase activity. CD45 
is the antagonist of tyrosine kinase of insulin receptor, whereas it can show high 
activity towards membrane-bound molecules (receptors of insulin and epidermal 
growth factor) [96, 99]. The increased content of sialoglycans in CD45 may cause 
masking of insulin receptors on organs and tissues, preventing the effect of mini-
mal amounts of the hormone, which can still be produced in type 1 diabetes. This 
effect may disimprove complications during the development of the disease [96].
The α2,6-sialylation of leukocyte glycoconjugates undergoes certain changes 
in type 1 DM (Figure 2) [100]. Therefore, the quantity of sialic acids linked by 
α2,6-glycosidic bonds correlate with the disease duration. The content of sialogly-
coconjugants on leukocytes surfaces increases for patients with the disease up to 
five years, while it decreases for patients with the disease duration over ten years. 
The pathology is accompanied by an increase of linkage places for SNA, which 
indicates the replacement of α2,3-linked sialic acids by α2,6-linked acids. It is likely 
to as a result of quantitative changes in the cells or in the enzyme activity of ST6Gal 
and/or ST6GalNAc [45]. The activity of α2,6 sialyltransferase decreases during the 
biosynthesis of O-glycans of T lymphocyte in the process of their activation. Thus, 
an increase in the content of α2,6-linked sialic acids of leukocyte cell surfaces along 
with a decline in the number of α2,3-linked sialic acids may indicate an increased 
sensibilization towards B lymphocyte stimulation and the inhibition of T lympho-
cyte activity under type 1 DM [20, 58].
6. Conclusions
Under cell–cell interaction, not only the presence of certain glycoconjugate, but 
also the type of linkage of sialic acids to the oligosaccharide chaine is informative. 
Against the general increase in the number of sialic acid-containing glycoconjugates 
on leukocytes surface under type 1 DM, there were small quantities of sialic acids 
linked by α2,3-glycosidic bond to subterminal carbohydrates in structure of glycans. 
Whereas, the quantity of sialic acid linked by α2,6-glycosidic bonds in the structure 
of sialoglycans correlated with the duration of diabetes. Such peculiarities of the 
structure of sialoglycoconjugates of leukocytes may affect both dynamic and kinetic 
indices of cell aggregation. Leukocytes aggregation affected by lectins may be used 
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of glycoconjugates on leukocytes membrane under type 1 DM causes changes in 
their aggregation and adhesion to the vascular endothelium, as well as impairment 
of the phagocytic function of neutrophils. Thus, the accumulation of leukocyte 
aggregates in microvessels and violation of disaggregation mechanisms lead to 
damage of blood vessels. Such changes are etiological preconditions for the develop-
ment of complications and chronic diseases resulting in deterioration in diabetics’ 
conditions.
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